Semaglutide hair loss is a medical condition which manifests as a decline in hair density, length, and/or thickness. It is a recognized adverse effect of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist medication prescribed for type 2 diabetes and obesity management.
As semaglutide's use has expanded, anecdotal reports and clinical trials have documented hair loss as a common side effect. This phenomenon has sparked interest due to its potential implications for patients using semaglutide for weight management or diabetes control.